Welcome to Labex Recombinant Proteins
Labex Recombinant Proteins is a biomanufacturing company specializing in novel technologies for the production of recombinant proteins for research and diagnostic use. We are dedicated to delivering high-quality products with precision and reliability. Our expert team focuses on advancing innovation to support global scientific and medical communities.
Key Features of our Next-Generation Production Technology
Cutting-Edge Recombinant Protein Production Technology
- Patented E.coli expression platform for high level extra-cellular production of recombinant proteins.
- Large basket of protein products made by this generic technology for research & diagnostic use.
- The proteins are highly pure > 98%.
- Properly folded proteins which exhibit the required biological activity in appropriate cell lines.
- Highly stable products under the defined storage conditions in both liquid & powder form as tested by ELISA.
- Available both with & without carrier proteins.
- Proteins do not contain any extra amino acid at N-terminal like methionine.
Key steps of our production process
REFERNCES
- Sharma, A.K., Shukla, E., Janoti, D.S. et al. A novel knock-out strategy to enhance recombinant protein expression in Escherichia coli. Microb Cell Fact 19, 148 (2020). Read More
- Ghosh, C., Gupta, R. & Mukherjee, K.J. An inverse metabolic engineering approach for the design of an improved host platform for over-expression of recombinant proteins in Escherichia coli. Microb Cell Fact 11, 93 (2012). Read More
- Mahalik, S., Sharma, A.K. & Mukherjee, K.J. Genome engineering for improved recombinant protein expression in Escherichia coli. Microb Cell Fact 13, 177 (2014). Read More
- Guleria, R., Jain, P., Verma, M. et al. Designing next generation recombinant protein expression platforms by modulating the cellular stress response in Escherichia coli. Microb Cell Fact 19, 227 (2020). Read More
- Bhattacharya, P., Pandey, G., Srivastava, P. et al. Combined effect of protein fusion and signal sequence greatly enhances the production of recombinant human GM-CSF in Escherichia coli . Mol Biotechnol 30, 103–115 (2005). Read More